Santaris Pharma, the Danish biopharmaceutical company, announced today that Dr Flemming Ørnskov, Chief Executive Officer of Lifecycle Pharma A/S, has been elected non-executive Chairman of Santaris Pharma A/S.

Dr Ørnskov takes over responsibilities from Santaris Pharma’s current Chairman, Martien van Osch, a general partner at Forbion Capital Partners, with immediate effect. Dr Ørnskov was appointed to the Santaris Pharma Board by shareholders at the Company’s Annual General Meeting on 24th May 2007 and elected Chairman by the Santaris Pharma Board immediately thereafter.